-+ 0.00%
-+ 0.00%
-+ 0.00%

CICC Initiates Coverage On Novo Nordisk with Outperform Rating, Announces Price Target of $73.5

Benzinga·01/09/2026 12:42:37
Listen to the news
CICC initiates coverage on Novo Nordisk (NYSE:NVO) with a Outperform rating and announces Price Target of $73.5.